OBJECTIVE: Interleukin-6 (IL-6), which is increased in patients who are suffering from septic shock, is an important mediator of the inflammatory response. Here, we examined the priming effect of lipoteichoic acid (LTA) and lipopolysaccharide (LPS) on IL-6 production in a monocyte-like cell line. METHODS: THP-1 cells were primed by treatingwith a low or high dose of LTA isolated from Staphylococcus aureus (aLTA) and then re-treated with LPS. IL-6 production, receptor expression, and the variation of signaling molecules were examined by ELISA, reverse transcriptase polymerase chain reaction, and western blotting, respectively. RESULTS: LPS-mediated IL-6 production was dramatically increased in THP-1 cells pretreated with a low dose aLTA, while it was significantly decreased when a high dose of aLTA was given along with LPS. LPS-induced IL-6 production in low dose aLTA priming cells mediated by NF-κB and MAPKs pathways, and Akt functioned as a negative regulator of IL-6 production. Together, the results of this study suggest that different doses of bacterial cell surface components can mediate a diverse range of responses with respect to inflammatory cytokine production.
OBJECTIVE:Interleukin-6 (IL-6), which is increased in patients who are suffering from septic shock, is an important mediator of the inflammatory response. Here, we examined the priming effect of lipoteichoic acid (LTA) and lipopolysaccharide (LPS) on IL-6 production in a monocyte-like cell line. METHODS: THP-1 cells were primed by treatingwith a low or high dose of LTA isolated from Staphylococcus aureus (aLTA) and then re-treated with LPS. IL-6 production, receptor expression, and the variation of signaling molecules were examined by ELISA, reverse transcriptase polymerase chain reaction, and western blotting, respectively. RESULTS:LPS-mediated IL-6 production was dramatically increased in THP-1 cells pretreated with a low dose aLTA, while it was significantly decreased when a high dose of aLTA was given along with LPS. LPS-induced IL-6 production in low dose aLTA priming cells mediated by NF-κB and MAPKs pathways, and Akt functioned as a negative regulator of IL-6 production. Together, the results of this study suggest that different doses of bacterial cell surface components can mediate a diverse range of responses with respect to inflammatory cytokine production.
Authors: Mansour Mohamadzadeh; Scott Olson; Warren V Kalina; Gordon Ruthel; Gretchen L Demmin; Kelly L Warfield; Sina Bavari; Todd R Klaenhammer Journal: Proc Natl Acad Sci U S A Date: 2005-02-14 Impact factor: 11.205
Authors: A Takala; I Jousela; S E Jansson; K T Olkkola; O Takkunen; A Orpana; S L Karonen; H Repo Journal: Clin Sci (Lond) Date: 1999-11 Impact factor: 6.124
Authors: Maria K Dahle; Gunhild Øverland; Anders E Myhre; Jon Fredrik Stuestøl; Thomas Hartung; Claus Danckert Krohn; Øystein Mathiesen; Jacob E Wang; Ansgar O Aasen Journal: Infect Immun Date: 2004-10 Impact factor: 3.441
Authors: Jeongmin Song; Matthew J Duncan; Guojie Li; Cheryl Chan; Richard Grady; Ann Stapleton; Soman N Abraham Journal: PLoS Pathog Date: 2007-04 Impact factor: 6.823
Authors: Kassia de Carvalho Dias; Paula Aboud Barbugli; Fernanda de Patto; Virginia Barreto Lordello; Letícia de Aquino Penteado; Alexandra Ivo Medeiros; Carlos Eduardo Vergani Journal: BMC Microbiol Date: 2017-06-30 Impact factor: 3.605
Authors: Lu Dai; Michael R DeFee; Yueyu Cao; Jiling Wen; Xiaofei Wen; Mairi C Noverr; Zhiqiang Qin Journal: PLoS One Date: 2014-06-27 Impact factor: 3.240